Dr. Ajit Singh is a CEO-Partner at Flagship Pioneering and CEO of Harbinger Health. Earlier, he was a partner at Silicon Valley based Artiman Ventures for 15 years, focused on early-stage technology and life science investments, with over $1 Billion in assets under management. He also serves on the Board of Trustees of American Association for Cancer Research (AACR) Foundation, the oldest and the largest cancer research organization globally.
Ajit is an Adjunct Professor in the School of Medicine at Stanford where he teaches clinical technologies and entrepreneurship.
Earlier, Ajit was the President and CEO of Biolmagene, a company specializing in AI-based Diagnostics, based in California. Biolmagene was acquired by Roche in September 2010. Before Biolmagene, Ajit spent nearly twenty years at Siemens in various roles, in the US, and in Germany, most recently as the global CEO of Siemens Oncology, and Siemens Digital Imaging Systems.
Ajit has a Ph.D. in Computer Science from Columbia University, a Master’s in computer engineering from Syracuse University, and a Bachelor’s in Electrical Engineering from Indian Institute of Technology in Varanasi, India. He has published two books and numerous refereed articles and holds five patents. His Top-10 Book Review is carried by various blogs and reading journals in December every year.
At the Wyss Institute, Ajit is a member of the Wyss Mentor Hive who specializes in technology and life science investments and business operation, with deep expertise in healthcare innovation, diagnostics, AI, and company leadership.
The Wyss Mentor Hive is a mentoring program that invites investors and business professionals with significant early stage translational experience, clinical and regulatory experts in driving therapeutic and device development, and serial entrepreneurs with a track record of success to work closely with Wyss entrepreneur teams on startup formation and technology commercialization. Mentors provide feedback to founders and entrepreneurs, while also demonstrating commitment and leadership in the Wyss innovation community.